Evidence map›Paper›PMID 38789103›Full record

ArticleJournal of agricultural and food chemistry2024

Investigating the Transepithelial Transport and Enzymatic Stability of Lactononadecapeptide (NIPPLTQTPVVVPPFLQPE), a 19-Amino Acid Casein-Derived Peptide in Caco-2 Cells.

Eriko Nakatani, Masaki Sasai, Hidetoshi Miyazaki, Shimako Tanaka, Tatsuhiko Hirota, Takashi Okura

Abstract read
In one paragraph

Article in Journal of agricultural and food chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Eriko NakataniLaboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.
Masaki SasaiCore Technology Laboratories, Asahi Quality and Innovations, Ltd., 1-1-21 Midori, Moriya, Ibaraki 302-0106, Japan.ORCID 0009-0001-8095-5450
Hidetoshi MiyazakiCore Technology Laboratories, Asahi Quality and Innovations, Ltd., 1-1-21 Midori, Moriya, Ibaraki 302-0106, Japan.
Shimako TanakaLaboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.
Tatsuhiko HirotaCore Technology Laboratories, Asahi Quality and Innovations, Ltd., 1-1-21 Midori, Moriya, Ibaraki 302-0106, Japan.
Takashi OkuraLaboratory of Pharmaceutics, Faculty of Pharmaceutical Sciences, Teikyo University, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactononadecapeptide (LNDP; NIPPLTQTPVVVPPFLQPE), a casein-derived peptide comprising 19 residues, is known for its capacity to enhance cognitive function. This study aimed to explore the transepithelial transport and stability of LNDP. Results showed that LNDP retained over 90% stability after 2 h of treatment with gastrointestinal enzymes. The stability of LNDP on Caco-2 cell monolayers ranged from 93.4% ± 0.9% to 101.1% ± 1.2% over a period of 15-60 min, with no significant differences at each time point. The permeability of LNDP across an artificial lipid membrane was very low with the effective permeability of 3.6 × 10

Indexed as

CaseinsBiological TransportCaco-2 CellsEnzyme StabilityHumansIntestinal MucosaPeptidesPeptide Transporter 1CaseinsPeptidesPeptide Transporter 1beta-caseinCaco-2 cellsintestinal transportlactononadecapeptide (LNDP)peptidepeptide transporter 1 (PEPT1)

Identifiers

PMID38789103
PMCPMC11157532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.